- Acute Asthma: Give Drug therapy for acute asthma as for non-pregnant patient including systemic steroids and magnesium sulphate
- Acute severe asthma in pregnancy is an emergency and should be treated vigorously in hospital
- Deliver high flow oxygen immediately to maintain saturation 94–98%
British Guideline on Management of Asthma
- Drug therapy should be given as for a non-pregnant patient with acute asthma, continuous nebulised β2 agonists and early administration of steroid tablets.
- In severe cases, intravenous β2 agonists, aminophylline, or intravenous bolus magnesium sulfate can be used as indicated
- Continuous fetal monitoring should be performed when asthma is uncontrolled or severe, or when fetal assessment on admission is not reassuring.
RECOMMENDATIONS
- For management of acute exacerbation, there is consistent evidence on the use of IV Magnesium Sulphate and also systemic steroids.
- No consistent evidence on the use of Subcutaneous Terbutaline. However they are still safe to be used in pregnancy
- For management of acute asthma overall the management is as for non-pregnant patients.
REFERENCES
- www.uptodate.com
- Medscape, http://www.medscape.org/viewarticle/569862
- http://www.guidelines.co.uk/btssign/asthma-in-pregnancy
- https://www.brit-thoracic.org.uk/document-library/clinical-information/asthma/btssign-guideline-on-the-management-of-asthma/
- Managing Asthma During Pregnancy: Recommendations for Pharmacologic Treatment https://www.nhlbi.nih.gov/files/docs/astpreg_qr.pdf
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.